Didanosine Catalog No.:M9257-10 Chemical Name: 4-[(1E

Chemical Name: 4-[(1E

146(231)197-121)198-135(220)106(51-38-68-175-152(166)167)185-137(222)116-54-41-71-202(116)143(228)113(76-94-80-177-100-45-29-27-43-98(94)100)192-128(213)103(48-35-65-172-149(160)161)183-126(211)102(181-91(15)203)47-34-64-171-148(158)159)145(230)193-111(77-95-81-168-82-178-95)134(219)195-119(85(7)8)139(224)186-104(49-36-66-173-150(162)163)127(212)184-105(50-37-67-174-151(164)165)129(214)194-120(86(9)10)140(225)191-110(75-93-79-176-99-44-28-26-42-97(93)99)132(217)182-101(46-33-63-170-147(156)157)125(210)169-62-32-24-25-55-117(205)179-89(13)124(209)187-107(72-83(3)4)130(215)180-90(14)142(227)201-70-40-53-115(201)138(223)189-109(74-92-56-58-96(204)59-57-92)133(218)196-122(88(12)19-2)144(229)200-69-39-52-114(200)123(155)208/h20-21

and weakly affects the progression of cell cycle in SKBr-3 cells (5-20 μM)

It is specific for class I and class II HDACs

Didanosine Catalog No.:M9257-10 Chemical Name: 4-[(1EDidanosine (2,3 dideoxyinosine, ddI, DDI) marketed under the trade names Videx and Videx EC. It is an antiretroviral medication used to treat HIV AIDS in combination with other medications as part of highly active antiretroviral therapy (HAART). It is of the reverse transcriptase inhibitor class. It is on the World Health Organization's List of Essential Medicines, a list of the most important medication needed in a basic health system. (Source: